Scarica l'app Stockscreener
18.61
6.10%
1.07
Dopo l'orario di chiusura:
18.67
0.06
+0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$17.54
Aprire:
$17.46
Volume 24 ore:
273.50K
Relative Volume:
0.82
Capitalizzazione di mercato:
$345.50M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-23.26
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
+2.08%
1M Prestazione:
+44.71%
6M Prestazione:
+252.46%
1 anno Prestazione:
+147.14%
Intervallo 1D:
$17.23
$18.62
Intervallo di 1 settimana:
$16.70
$18.62
Portata 52W:
$3.78
$18.96
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Confronta OPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
18.61 | 318.58M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
270.06 | 44.25B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
78.12 | 13.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
68.52 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
97.70 | 7.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.23 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
Best Growth Stocks to Buy for September 3rd - Zacks Investment Research
Real time scanner hits for OptimizeRx Corporation explainedTrend Reversal & Daily Volume Surge Signals - Newser
Is it time to cut losses on OptimizeRx CorporationQuarterly Earnings Report & Verified Trade Idea Suggestions - Newser
Can OptimizeRx Corporation recover in the next quarter2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Real time breakdown of OptimizeRx Corporation stock performanceQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
Will OptimizeRx Corporation continue its uptrendInsider Buying & Long-Term Capital Growth Strategies - Newser
Can OptimizeRx Corporation outperform in the next rallyMarket Trend Review & Verified Short-Term Plans - khodrobank.com
How institutional ownership impacts OptimizeRx Corporation stockPortfolio Risk Report & Safe Swing Trade Setup Alerts - Newser
Real time alert setup for OptimizeRx Corporation performanceJuly 2025 WrapUp & Fast Gain Stock Tips - Newser
Relative strength of OptimizeRx Corporation in sector analysisWeekly Trend Recap & Verified Short-Term Plans - Newser
Real time pattern detection on OptimizeRx Corporation stockQuarterly Growth Report & AI Forecast for Swing Trade Picks - Newser
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - sharewise.com
OptimizeRx Corp. (OPRX) Shows Strong Momentum, A Strong Buy Candidate - AInvest
What Fibonacci levels say about OptimizeRx Corporation reboundJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Published on: 2025-09-03 01:47:39 - Newser
How to escape a deep drawdown in OptimizeRx CorporationTrade Entry Report & Free Daily Entry Point Trade Alerts - Newser
What indicators show strength in OptimizeRx Corporation2025 Market Overview & Reliable Volume Spike Alerts - Newser
Chart overlay techniques for tracking OptimizeRx Corporation2025 EndofYear Setup & Intraday High Probability Alerts - Newser
Trend analysis for OptimizeRx Corporation this weekWeekly Market Report & Daily Chart Pattern Signals - Newser
Chart based analysis of OptimizeRx Corporation trends2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Quantitative breakdown of OptimizeRx Corporation recent moveOptions Play & Reliable Entry Point Trade Alerts - Newser
What the charts say about OptimizeRx Corporation todayVolume Spike & AI Driven Stock Reports - Newser
What to expect from OptimizeRx Corporation in the next 30 days2025 EndofYear Setup & Long Hold Capital Preservation Tips - Newser
What MACD and RSI say about OptimizeRx Corporation2025 Top Decliners & Community Consensus Trade Signals - Newser
Is OptimizeRx Corporation stock bottoming outMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
Applying big data sentiment scoring on OptimizeRx Corporation2025 Analyst Calls & Safe Entry Point Identification - Newser
Short interest data insights for OptimizeRx Corporation2025 Macro Impact & Daily Volume Surge Signals - Newser
Applying Elliott Wave Theory to OptimizeRx CorporationTreasury Yields & Daily Oversold Stock Bounce Ideas - Newser
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Optimizerx Corp Azioni (OPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lang James Paul | Director |
Mar 14 '25 |
Buy |
7.60 |
321,408 |
2,443,761 |
389,452 |
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
2.53%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):